Tarsus Pharmaceuticals, Inc. TARS Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s intangibles (net)?
- Tarsus Pharmaceuticals, Inc. (TARS) reported intangibles (net) of $7.13M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s intangibles (net) changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s intangibles (net) decreased by 11.9% year-over-year, from $8.09M to $7.13M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s intangibles (net)?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s intangibles (net) has grown at a 47.8% compound annual growth rate (CAGR), from $1.05M to $7.37M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.